Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: Crispin Odey, Michael Hintze & Boaz Weinstein

Page 1 of 2

October Shorts Undo Gains for Crispin Odey’s Hedge Fund (WSJ)
Crispin Odey, one of the best-known hedge fund managers in Europe, has seen returns at his flagship €1.8 billion ($2.3 billion) hedge fund fall by more than 10% this year, after fresh losses in October undid the gains of late summer. According to the U.K. hedge fund manager’s latest report to investors, seen by MoneyBeat, the Cayman-domiciled Odey European Fund registered a 5.6% loss over the month, leaving it down 10.3% for the year to Oct. 31. Odey Asset Management did not provide comment in time for publication.

Crispin Odey

Icahn expects major stocks correction in 3 to 5 years (JamesTownSun)
Carl Icahn isn’t forecasting a dramatic stock market drop quite yet, but the billionaire investor is still bracing for a market sell-off in the next three to five years, he told Reuters on Monday. “I am still concerned that one day you’ll see a break like you had a few weeks ago,” Icahn said at the Reuters Investment Outlook Summit in New York on Monday, “but it won’t come back.” With the Standard & Poor’s 500 index now up more than 10 percent for the year and trading at 2,041, many investors have put October’s short-lived slide behind them, saying low interest rates and a growing mergers and acquisitions boom will continue to fuel the bull market.

Saba Capital Down 2.8% In October (Finalternatives)
Boaz Weinstein’s Saba Capital Management LP posted a 2.8 percent October loss in its main hedge fund as it heads for its third yearly decline. The Saba Capital Master Fund slumped 6.8 percent this year through October, according to a performance update, a copy of which was obtained by Bloomberg News. The fund fell 6.8 percent last year and 3.9 percent in 2012 after climbing 9.3 percent in 2011 and 11 percent in 2010. Weinstein’s fund has struggled since July 2012 as central bank intervention damped volatility and bolstered credit markets…

Hedge Fund Qualms Stoke TransCanada Debt Concern (BusinessWeek)
An activist hedge fund’s proposal to break up TransCanada Corporation (NYSE:TRP), timed to collide with a vote on its Keystone XL pipeline, is triggering concern the company is seeking to placate shareholders at the expense of bondholders. The cost to protect TransCanada debt from default surged to 93 basis points, the highest level since June 2012, following a letter to TransCanada’s board this week from billionaire investor Thomas Sandell’s Sandell Asset Management Corp. calling on it to speed up the transfer of U.S. assets to a tax-advantaged partnership and spin out its power business.

Hedge fund Livermore calls for board change at Volt Information (Reuters)
Hedge fund Livermore Partners is pushing for change at U.S. staffing services provider Volt Information Sciences, Inc. (NYSEMKT:VISI), setting the stage for a potential proxy battle if the company does not act on its demands. The fund called on Wednesday for Volt to overhaul its board by adding independent directors. It also wants it to sell non-core assets and buy back stock, said David Neuhauser, Livermore’s managing director. “It is imperative that both management and the board fully grasp the need to directly attack the current issues that are impairing shareholder equity,” he said in a letter addressed to Volt Chief Executive Ronald Kochman and seen by Reuters.

Is 120 likely for dollar-yen? (CNBC)

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!